Etafenone

Etafenone

SCHEMBL4715940

CCN(CC)CCOc1ccccc1C(=O)CCc1ccccc1.CN(C)CCCOC1(Cc2ccccc2)CCCCCC1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 16/20 0.48
▸ TSHR P16473 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ SCN1A P35498 1/20 0.41
▸ SCN2A Q99250 1/20 0.41
▸ SCN3A Q9NY46 1/20 0.41
▸ KCNK3 O14649 1/20 0.40
▸ SLC22A1 O15245 1/20 0.40
▸ ABCC9 O60706 1/20 0.40
▸ KCNK2 O95069 1/20 0.40
▸ ABCB11 O95342 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ ADRB2 P07550 1/20 0.40
▸ ADRB1 P08588 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ ADRB3 P13945 1/20 0.40
▸ ADRA2C P18825 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Etafenone SCHEMBL77987 0.81 ABCB1 (0.67) ABCB1TSHRALDH1A1LMNAKDM4E
Etafenone SCHEMBL29406308 0.81 ABCB1 (0.67) ABCB1TSHRALDH1A1LMNAKDM4E
Etafenone SCHEMBL219823 0.80 ABCB1 (0.66) ABCB1TSHRALDH1A1LMNAKDM4E
Etafenone SCHEMBL29846308 0.80 ABCB1 (0.66) ABCB1TSHRALDH1A1LMNAKDM4E
Etafenone SCHEMBL1651223 0.79 ABCB1 (0.65) ABCB1TSHRALDH1A1LMNAKDM4E
Bencyclane SCHEMBL64881 0.76 AQP3 (0.44) ALDH1A1KDM4ECYP1A2CYP2D6SLC6A2
Bencyclane SCHEMBL220903 0.75 HRH1 (0.52) ALDH1A1LMNAKDM4ESMN1; SMN2
Bencyclane SCHEMBL1568812 0.75 HRH1 (0.52) ALDH1A1LMNAKDM4ESMN1; SMN2
Bencyclane SCHEMBL20505617 0.74 HRH1 (0.51) ALDH1A1LMNAKDM4ESMN1; SMN2
Etafenone SCHEMBL13724598 0.70 ABCB1 (0.53) ABCB1TSHRALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993541-A2 ANTIHYPERTENSIVE THERAPY Gilead Colorado, Inc. (US) 2008-11-26 — — EP disclosed
WO-2007098387-A2 ANTIHYPERTENSIVE THERAPY GILEAD COLORADO, INC. (US) 2007-08-30 — — WO disclosed
Send feedback